Your are not logged in. | login
MPN&MPNr-EuroNet



about MPN&MPNr-EuroNet

Chair

Dr. Sylvie HERMOUET

Laboratoire d'Hématologie
Institut de Biologie
INSERM U892
Institut de Recherche Thérapeutique
8-9 Quai Moncousu
44007 Nantes Cedex 1
France

Logistic Organizer



Batumi
Conference & Event Agency

Sponsored by



BIOMEDICA


EPPENDORF Poland



QIAGEN


SARSTEDT

Preliminary Programme

Diagnostic of Sporadic and Hereditary
Myeloproliferative Diseases

WEDNESDAY April 25th, 2018

 
17:30 - 18:00 Registration
18:00 - 18:20 Welcome and Schedule
 
18:20 - 19:30 Special Session I: Mutations in MPNs Chair: Tomasz Sacha (PL)
18:50 - 19:20 Mutations and their clinical relevance in myeloproliferative neoplasms Grzegorz Helbig (PL)
19:20 - 19:40 Diagnostic and prognostic significance of molecular testing in myelofibrosis Tomasz Sacha (PL)
 
20:00 Welcome Dinner
 

THURSDAY April 26th, 2018

 
08:30 - 10:30 WG1 session: Mutation detection and validation Chair: Beatriz Bellosillo (ES)
08:30 - 09:00 Mutational analyses in the era of next generation sequencing Katerina Machova Polakova (CZ)
09:00 - 09:30 Employing NGS to describe the genomic landscape of triple-negative MPNs Tomasz Stokłosa (PL)
10:20 - 10:30 Short talk from abstract selection To be announced
 
10:30 - 11:00 Coffee/tea break
 
11:00 - 13:00 WG2 session: Mutation quantification and MRD Chair: Niels Pallisgaard (DK)
12:50 - 13:00 Short talk from abstract selection To be announced
 
13:00 - 14:30 Lunch and Free Time for Networking and Poster Session
 
14:30 - 16:30 WG3 session: Hereditary Erythrocytosis Chair: Mary Frances McMullin (UK)
14:30 - 15:05 A Gain-of-Function Mutation in EPO causes Familial Erythrocytosis Jakub Zmajkovic (CH)
16:20 - 16:30 Short talk from abstract selection To be announced
 
16:30 - 17:00 Coffee/tea break
 
17:00 - 18:00 Business sessions in small groups
 
20:00 Gala Dinner at “Szara Gęś” Restaurant
 

FRIDAY April 27th, 2018

 
09:00 - 11:00 Special session II: Inflammation and immune response in MPNs Chair: François Girodon (FR)
09:00 - 09:35 Inflammatory cytokines in MPNs: Potential biomarkers and drivers of disease progression Nina Friesgaard Øbro (UK)
09:35 - 10:15 Impact of HSP27 in myelofibrosis as a new regulator of the JAK2/STAT5 signaling Aurélie de Thonel (FR)
10:15 - 10:50 Immune response to glycolipidic antigens in MPNs and other chronic hematological diseases Sylvie Hermouet (FR)
10:50 - 11:00 General discussion
 
11:00 - 11:30 Coffee/tea break
 
11:30 - 12:30 General business session
 
12:30 - 13:30 Lunch
12:30 - 13:30 Meeting Adjourn - Good bye